Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Stem Cell Therapeutics Corp. Announces Publication Of Phase I Stroke Data
Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE:SSS) is pleased to announce the acceptance and publication of the paper entitled "Open labeled, uncontrolled pharmacokinetic study of single intramuscular hCG dose in healthy male volunteers" by the International Journal of Clinical Pharmacology and Therapeutics, Vol. 47, August 2009. This paper was authored by Drs. Alan Moore, President & CEO, Allen Davidoff, VP Product Development and Yan Yang, Clinical Research Associate, all of SCT; Dr. Michael D. Hill of Foothills Hospital at the University of Calgary, and Dr. Steven C. Cramer, from the University of California, Irvine.

THT Launches New Campaign Encouraging Gay Men To 'THIVK - Test - Take Control
In a bid to reduce dangerous levels of undiagnosed HIV among gay men, Terrence Higgins Trust (THT) is launching a new campaign encouraging men to take control of their sexual health by regularly testing for HIV. The campaign "THIVK - Test - Take Control" will be run through a stand-alone website (http://www.thinkHIV.co.uk), adverts in gay press, posters, leaflets and condom packs, carrying the following messages:
News of the day
More Attention To Non-motor Manifestations Of Parkinson's Disease
An important problem of patients with PD is not related to dopamine deficit. "PD patients suffer not only of motor but also of such non-motor disturbances as sleep disturbances, depression, psychosis, hallucinations or dementia. These disturbances require a precise diagnostic work up and specific, usually non dopaminergic medications." A whole series of studies being presented at the ENS meeting are devoted to this problem area.
Health Insurance

Erythropoietin Boosts Brainpower

Healthy young mice treated with erythropoietin show lasting improved performance in learning and other higher brain functions. Researchers writing in the open access journal BMC Biology tested the cognitive effects of the growth factor, finding that it improved the sequential learning and memory components of a complex long-term cognitive task. Hannelore Ehrenreich led a team of researchers from the Max Planck Institute of Experimental Medicine in Gç¶ttingen, Germany, who studied the mice. She said, "Erythropoietin has been in clinical use for over 20 years to treat patients with anemic conditions, ranging from renal failure to cancer. It has recently received attention for its apparent ability to improve cognitive function in people with schizophrenia and multiple sclerosis. Here, we sought to investigate erythropoietin"s effects in healthy mice". Ehrenreich and her colleagues tested the effects of erythropoietin on the ability of the mice to learn how to exploit an experimental set-up to receive sugared water. Over a series of learning stages, the mice were trained to get their treat by poking their noses into holes lit by LEDs, rather than into unlit holes, within a time limit. The mice that had been treated with recombinant human erythropoietin were significantly more likely to master the task than those that had not. According to Ehrenreich, "Treated mice showed superior performance in associative, operant and discriminant learning as well as in the initial training phases. Moreover, erythropoietin-treated mice demonstrated better task adaptation and higher performance stability". The researchers conclude, "Further untangling of molecular mechanisms of erythropoietin action on higher cognitive functions may ultimately open new avenues for prevention strategies and therapeutic interventions in neuropsychiatric diseases". Notes: Erythropoietin improves operant conditioning and stability of cognitive performance in mice Ahmed El-Kordi, Konstantin Radyushkin and Hannelore Ehrenreich BMC Biology Graeme Baldwin BioMed Central


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009